AC75 Pill - white oval, 18mm
Pill with imprint AC75 is White, Oval and has been identified as Etravirine 100 mg. It is supplied by Amneal Pharmaceuticals LLC.
Etravirine is used in the treatment of HIV Infection and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Etravirine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for AC75
Etravirine
- Imprint
- AC75
- Strength
- 100 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- NNRTIs
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amneal Pharmaceuticals LLC
- National Drug Code (NDC)
- 60219-1721
See also:
Biktarvy
Biktarvy is a complete HIV-1 treatment in a once-a-day single tablet containing three antiviral ...
Descovy
Descovy is used to treat and prevent HIV infection in adults and adolescents. When used for HIV-1 ...
Cabenuva
Cabenuva (cabotegravir and rilpivirine) injections are a long-acting HIV treatment used to keep HIV ...
Truvada
Truvada is used to prevent HIV (HIV PrEP) or treat HIV-1 infection in combination with other HIV-1 ...
Atripla
Atripla prevents the human immunodeficiency virus (HIV) from reproducing in your body. Learn about ...
Complera
Complera (emtricitabine, rilpivirine, and tenofovir) is used to treat HIV infection. Includes ...
Stribild
Stribild (cobicistat, elvitegravir, emtricitabine and tenofovir) is used to treat HIV-1 infection ...
Epzicom
Epzicom is used to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). Learn ...
Emtricitabine
Emtricitabine is used for HIV Infection, nonoccupational exposure, occupational exposure
More about etravirine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: NNRTIs
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.